Personalized Testing and Supplements Market Size to Surpass USD 7.74 Billion by 2034

Market Highlights

• The North America segment held a dominant presence in the market in 2024, accounting for an estimated 40% market share.
• The Asia Pacific segment is expected to grow at the fastest CAGR of in the market during the 20% from 2025 to 2034.
• By product type, the nutrition supplements segment accounted for a considerable share of 65% in 2024.
• By product type, the personalized testing segment is expanding at a strong CAGR from 2025 to 2034.
• By service type, the genetic testing services segment led the market, accounting for an estimated 40% market share in 2024.
• By service type, the consultation & personalized recommendations segment is expanding at a solid CAGR from 2025 to 2034.
• By delivery format, the oral supplements segment contributed the biggest market share of 55% in 2024.
• By delivery format, the functional foods & beverages segment is anticipated to grow with the highest CAGR between 2025 and 2034.
• By application, the general wellness segment dominated the market, accounting for an estimated 50% market share in 2024.
• By application, the sports and wellness segment is projected to grow at a notable CAGR from 2025 to 2034.
• By end-user, the individual consumers segment held the major market share of 60% in 2024.
• By end-user, the healthcare & clinics segment is expected to grow at a strong CAGR from 2025 to 2034.

Market Overview

The personalized nutrition and testing market is witnessing robust growth, driven by increasing consumer awareness of preventive healthcare and the demand for tailored nutrition solutions. Consumers are moving away from one-size-fits-all supplements toward personalized approaches that align with their unique biology, lifestyle, and health goals.

At the core of this market’s expansion are technological advancements in genetic sequencing, microbiome analysis, metabolic biomarker studies, and AI-driven algorithms. These technologies enable the integration of biological and lifestyle data to deliver customized testing insights and supplement recommendations.

A key initiative accelerating this trend is the NIH Nutrition for Precision Health program, which has committed US$170 million to recruit 10,000 participants and develop AI-based algorithms that predict individual responses to food and dietary patterns using genetic and microbiome data.

Additionally, the rapid adoption of wearable biosensors, mobile health applications, and AI-powered analytics is empowering users to receive real-time feedback on nutritional intake and supplement efficacy. This convergence of digital health technologies and biological data is driving a fundamental shift toward personalized, data-driven wellness solutions, positioning the market for sustained long-term growth.

Impact of Artificial Intelligence on the Personalized Testing & Supplements Market

Artificial intelligence (AI) is transforming genetic, metabolic, and lifestyle data into practical health-sensitive information. Firms are combining AI-based analytics with testing systems to decipher DNA sequences, microbiome compositions, and biomarker concentrations with greater accuracy than before. Furthermore, the nutritionists and health-technology companies can use this technology to create an individualized type of supplement targeted at addressing a particular deficiency.

Personalized Testing and Supplements Market Growth Factors

• Rising Consumer Awareness of Preventive Health: Growing public understanding of nutrition–genomics links is fuelling demand for DNA-based testing and customized supplement solutions.
• Expanding Integration of AI and Data Analytics: Advancements in artificial intelligence are driving more precise health assessments and boosting the adoption of data-driven personalization platforms.
• Growing Influence of Digital Health Ecosystems: The increasing use of mobile health apps and connected wearables is propelling continuous monitoring and individualized supplement recommendations.
• Surging Investment in Nutrigenomics Research: Rising funding from public health agencies and private investors is fuelling breakthroughs in genotype-based nutrition science.

Regional Insights

North America holds a dominant share of the personalized nutrition and testing market, driven by a strong focus on preventive healthcare, high adoption of digital health technologies, and the growing presence of AI-driven nutrition startups. Major healthcare initiatives such as the NIH Nutrition for Precision Health program are propelling research and innovation in the U.S., while increasing consumer demand for personalized diet and supplement plans continues to drive commercial adoption.

Europe represents a significant market, supported by strong regulatory frameworks for nutrigenomics and health data, government-funded research programs, and growing awareness of precision health. Countries such as Germany, the U.K., and the Netherlands are leading in integrating genetic and microbiome-based nutrition into clinical and consumer wellness settings.

Asia-Pacific is projected to experience the fastest growth, fueled by expanding middle-class populations, increased digital health adoption, and growing awareness of lifestyle-related diseases. Rising investments in AI-driven health platforms and nutrigenetic testing services in countries like China, Japan, South Korea, and India are accelerating the market expansion in this region.

Latin America and the Middle East & Africa are emerging markets with rising health awareness and improving healthcare infrastructure. The adoption of mobile health apps and at-home testing kits is gaining momentum, particularly among urban populations seeking affordable and accessible personalized health insights.